Ablynx NV

Ablynx NV

Sector: Commercial Physical And Biological Research Region: Belgium

: | Euronext Brussels: ABLXS | Euronext Brussels: ABLX | OTC Markets: ABLYF

Similar to: Medivir AB, Advanced Cell Technology, Inc., Cerep SA

Ablynx NV engages in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for serious and life-threatening human diseases, including inflammation, hematology, oncology and pulmonary disease. The company was founded on July 4, 2001 and is headquartered in Ghent, Belgium.

News & Analysis

You may also be interested in: